Objective: Some patients with intact abdominal aortic aneurysm (iAAA) have consumption coagulopathy without definitive diagnosis of disseminated intravascular coagulation (DIC). The objective of this study was to reveal the clinical significance of such marginal coagulopathy (namely, pre-DIC) associated with iAAA.
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Early and Late Costs of Endovascular Abdominal Aortic Aneurysm Repair From the Endurant Stent Graft System Post Approval Study (ENGAGE PAS)
Objective: Endovascular aneurysm repair (EVAR) has become the standard of care for treatment of abdominal aortic aneurysms. Whereas the costs of EVAR during the index admission were shown with early randomized trials, these studies evaluated costs with early devices and had nothing to disclose regarding follow-up costs. Therefore, we present the early and late costs of EVAR from the Endurant Stent Graft System Post Approval Study (ENGAGE PAS).
Methods: From August 2011 to June 2012, there were 178 patients enrolled in ENGAGE PAS and treated with the Medtronic Endurant stent graft system (Medtronic, Santa Rosa, Calif) . Cost data for the index and follow-up hospitalizations were tabulated directly from hospital bills and categorized by Uniform Billing (UB-04) codes. Surgeon costs were calculated by Current Procedural Terminology codes for each intervention, and these codes were also used to impute annual imaging and clinic follow-up costs.
Results: A total of 178 patients underwent EVAR with the Endurant graft, and 171 consented for inclusion in the economic analysis. The mean total hospital cost per person for the index EVAR was $38,355, with a range from $4972 to $686,928 (Table) . Cost of the EVAR device accounted for 52% of the total cost at a mean of $20,000 per person. Annual follow-up imaging costs averaged $693, whereas annual office visits averaged $99, for a total routine follow-up cost of $792 per year. During a median follow-up of 37 months, 12 patients (7.0%) underwent 16 reinterventions. The mean cost associated with reintervention was $35,011 per person.
Conclusions: Costs associated with EVAR are driven primarily by the cost of the device. Late reintervention is uncommon, but when it occurs, it is associated with costs similar to those of the index procedure. These data will serve as a baseline for comparison with open repair and other devices. Objective: Reporting standards in clinical research allow accurate comparison between outcomes for different clinical trials. We sought to assess the proportion of published studies evaluating outcomes for elective infrarenal endovascular aneurysm repairs (EVARs) that adhered to the current Society for Vascular Surgery (SVS) reporting guidelines.
IP061.
Reporting Standards for Infrarenal
Methods: We searched PubMed indexed randomized clinical trials (RCTs) and multicenter cohort studies (MCSs) between January 1, 2010, and December 1, 2017. We identified and reviewed studies that reported clinical outcomes for infrarenal abdominal aortic aneurysm undergoing elective EVAR. We evaluated whether the following outcomes were reported at all: aneurysm rupture, aneurysm-related death, primary and secondary technical success, clinical success or clinical failure, and longitudinal outcomes; we then evaluated whether these outcomes were reported according to the current SVS reporting guidelines for EVAR (Chaikof et al, 2002) .
Results: Thirty studies that investigated infrarenal EVAR outcomes were included in our analysis: 7 RCTs and 23 MCSs. Of the 30 studies, 
